François-Xavier Mahon

4.6k citations
11 papers · 1.0k indexed · 1 hit paper · h-index 10
Topics
Chronic Myeloid Leukemia Treatments (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)Eosinophilic Disorders and Syndromes (6 papers)
Partner nations
FranceSpainAustralia

In The Last Decade

François-Xavier Mahon

11 papers receiving 1.0k citations

Hit Papers

Adherence Is the Critical Factor for Achieving Molecular ...20102026201520202010200400600

Peers

François-Xavier Mahon
Comparison fields: 5 of 59
  • Hematology 830
  • Genetics 721
  • Rheumatology 368
  • Oncology 139
  • Family Practice 126
Replace Christos Paliompeis with:
Christos Paliompeis United Kingdom
Marzia Salvucci Italy
Clarisse Lobo Brazil
Kejal Parikh United States
Carolina Pavlovsky Argentina
Ida Carmosino Italy
Stephanie Zrim Australia
Uma Borate United States
Nina Gulbrandsen Norway
Richard van der Jagt Canada
François-Xavier Mahon relative to Christos Paliompeis United Kingdom Christos Paliompeis's profile →
Citations per field
00.5×1.5×
Christos Paliompeis · 1×
Citations per year

Countries citing papers authored by François-Xavier Mahon

Since Specialization
Citations

This map shows the geographic impact of François-Xavier Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François-Xavier Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François-Xavier Mahon more than expected).

Fields of papers citing papers by François-Xavier Mahon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François-Xavier Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François-Xavier Mahon. The network helps show where François-Xavier Mahon may publish in the future.

Co-authorship network of co-authors of François-Xavier Mahon

This figure shows the co-authorship network connecting the top 25 collaborators of François-Xavier Mahon. A scholar is included among the top collaborators of François-Xavier Mahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François-Xavier Mahon. François-Xavier Mahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 26
2 11
3 95
4 13
5 24
6 75
7 32
8
Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinibbreakdown →
674
9 35
10 5
11 49

About François-Xavier Mahon

François-Xavier Mahon is a scholar working on Hematology, Genetics and Rheumatology, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Hematology (830 citations), Genetics (721 citations) and Family Practice (126 citations). François-Xavier Mahon has collaborated with scholars based in France, Spain and Australia. Frequent co-authors include David Marín, Christos Paliompeis, Alistair Reid, Mathiéu Molimard, Victoria Latham, Kasia Kozlowski, Lina Eliasson, Hugues de Lavallade, Alexandra Bazeos and Dragana Milojković. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026